Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 146

    1.

    Aspartame not linked to cancer.

    Abegaz EG.

    Environ Health Perspect. 2007 Jan;115(1):A16-7; author reply A17. No abstract available. PMID: 17366802 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Sweetening agents: saccharin--cyclamate and its metabolites--aspartame]

    Lederer J.

    Rev Med Suisse Romande. 1980 Jan;100(1):87-100. Review. French. No abstract available. PMID: 6770435 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Sweetening agent aspartame as carcinogen?]

    [No authors listed]

    Kinderkrankenschwester. 2006 Feb;25(2):82. German. No abstract available. PMID: 16604954 [PubMed - indexed for MEDLINE]Related articles

    4.

    Response to "the effect of aspartame on the acetylcholinesterase activity in hippocampal homogenates of suckling rats" by Simintzi et al.

    Abegaz EG, Bursey RG.

    Pharmacol Res. 2008 Jan;57(1):87-8; author reply 89-90. Epub 2007 Oct 9. No abstract available. PMID: 18063380 [PubMed - indexed for MEDLINE]Related articles

    5.

    Sour finding on popular sweetener.

    Mead MN.

    Environ Health Perspect. 2006 Mar;114(3):A176. No abstract available. PMID: 16528837 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats.

    Soffritti M, Belpoggi F, Tibaldi E, Esposti DD, Lauriola M.

    Environ Health Perspect. 2007 Sep;115(9):1293-7.PMID: 17805418 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Letter: Aspartame as a sweetener.

    Olney JW.

    N Engl J Med. 1975 Jun 5;292(23):1244-5. No abstract available. PMID: 1128585 [PubMed - indexed for MEDLINE]Related articles

    8.

    Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.

    Magnuson BA, Burdock GA, Doull J, Kroes RM, Marsh GM, Pariza MW, Spencer PS, Waddell WJ, Walker R, Williams GM.

    Crit Rev Toxicol. 2007;37(8):629-727. Review.PMID: 17828671 [PubMed - indexed for MEDLINE]Related articles

    9.

    First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats.

    Soffritti M, Belpoggi F, Degli Esposti D, Lambertini L, Tibaldi E, Rigano A.

    Environ Health Perspect. 2006 Mar;114(3):379-85.PMID: 16507461 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Results of long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed.

    Belpoggi F, Soffritti M, Padovani M, Degli Esposti D, Lauriola M, Minardi F.

    Ann N Y Acad Sci. 2006 Sep;1076:559-77.PMID: 17119233 [PubMed - indexed for MEDLINE]Related articles

    11.

    Aspartame bioassay findings portend human cancer hazards.

    Huff J, LaDou J.

    Int J Occup Environ Health. 2007 Oct-Dec;13(4):446-8.PMID: 18085058 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comments on the purported generation of formaldehyde and adduct formation from the sweetener aspartame.

    Tephly TR.

    Life Sci. 1999;65(13):PL157-60.PMID: 10503962 [PubMed - indexed for MEDLINE]Related articles

    13.

    The effect of aspartame on acetylcholinesterase activity in hippocampal homogenates of suckling rats.

    Simintzi I, Schulpis KH, Angelogianni P, Liapi C, Tsakiris S.

    Pharmacol Res. 2007 Aug;56(2):155-9. Epub 2007 May 13.PMID: 17580119 [PubMed - indexed for MEDLINE]Related articles

    14.

    The effect of aspartame metabolites on the suckling rat frontal cortex acetylcholinesterase. An in vitro study.

    Simintzi I, Schulpis KH, Angelogianni P, Liapi C, Tsakiris S.

    Food Chem Toxicol. 2007 Dec;45(12):2397-401. Epub 2007 Jun 16.PMID: 17673349 [PubMed - indexed for MEDLINE]Related articles

    15.

    Carcinogenicity of aspartame in rats not proven.

    Magnuson B, Williams GM.

    Environ Health Perspect. 2008 Jun;116(6):A239-40; author reply A240. No abstract available. PMID: 18560494 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Aspartame: review of safety.

    Butchko HH, Stargel WW, Comer CP, Mayhew DA, Benninger C, Blackburn GL, de Sonneville LM, Geha RS, Hertelendy Z, Koestner A, Leon AS, Liepa GU, McMartin KE, Mendenhall CL, Munro IC, Novotny EJ, Renwick AG, Schiffman SS, Schomer DL, Shaywitz BA, Spiers PA, Tephly TR, Thomas JA, Trefz FK.

    Regul Toxicol Pharmacol. 2002 Apr;35(2 Pt 2):S1-93. Review.PMID: 12180494 [PubMed - indexed for MEDLINE]Related articles

    17.

    Letter to U.S. FDA commissioner. Questions about the safety of the artificial sweetener aspartame.

    Abdo KM, Camargo CA Jr, Davis D, Egilman D, Epstein SS, Froines J, Hattis D, Hooper K, Huff J, Infante PF, Jacobson MF, Teitelbaum DT, Tickner JA.

    Int J Occup Environ Health. 2007 Oct-Dec;13(4):449-50. No abstract available. PMID: 18085059 [PubMed - indexed for MEDLINE]Related articles

    18.

    Sweeteners: how the brands measure up.

    [No authors listed]

    Consum Rep. 2007 Oct;72(10):16-7. No abstract available. PMID: 17912797 [PubMed - indexed for MEDLINE]Related articles

    19.

    Aspartame and brain cancer.

    Roberts HJ.

    Lancet. 1997 Feb 1;349(9048):362. No abstract available. PMID: 9024408 [PubMed - indexed for MEDLINE]Related articles

    20.

    Aspartame and other sweeteners.

    [No authors listed]

    Conn Med. 1982 Jul;46(7):411. No abstract available. PMID: 7116843 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data